1.
|
Phase: Phase III Type: Prevention, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: KROG-4-2008-0276, 4-2008-0276, NCT00955695
|
|
2.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 21 to 70 Sponsor: NCI, Other Protocol IDs: 2007NT127, R01CA122244, 0712M22651, UMN-2007NT127, PEITC, NCT00691132
|
|
3.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 45 to 79 Sponsor: NCI Protocol IDs: MAYO-MAY06-8-01, MAY06-8-01, NCT00783705
|
|
4.
|
Phase: Phase I Type: Behavioral study, Prevention Status: Active Age: 18 to 85 Sponsor: Other Protocol IDs: 1104008332, NCT01479998
|
|
5.
|
Phase: No phase specified Type: Behavioral study, Prevention Status: Approved-not yet active Age: 3 and under Sponsor: Other Protocol IDs: Krebshilfe-107539, DM8-IESO02, NCT00647413
|
|
6.
|
Phase: No phase specified Type: Behavioral study, Prevention Status: Active Age: 20 to 60 Sponsor: Other Protocol IDs: SPCRU1, NCT01176383
|
|
7.
|
Phase: No phase specified Type: Behavioral study, Educational/Counseling/Training, Prevention Status: Active Age: 18 to 90 Sponsor: Other Protocol IDs: 09/WMW01/28, WS763986, NCT01192256
|